Oral anticoagulants: their role in AF management

There is a largely under-appreciated AF (inclusive non-valvular AF) prevalence in Australia.

It is estimated that 5.35% of the adult population aged ≥ 55 years are affected by AF.

Opportunistic screening for silent AF seems cost-effective in elderly patients, and similar effects reported using single-lead ECG screening in other at-risk populations.